Pfizer Inc (PFE)
25.26
-1.01
(-3.84%)
USD |
NYSE |
Apr 25, 16:00
25.40
+0.14
(+0.55%)
After-Hours: 20:00
Pfizer Price to Book Value: 1.603 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 1.666 |
| April 23, 2024 | 1.670 |
| April 22, 2024 | 1.666 |
| April 19, 2024 | 1.649 |
| April 18, 2024 | 1.611 |
| April 17, 2024 | 1.613 |
| April 16, 2024 | 1.630 |
| April 15, 2024 | 1.644 |
| April 12, 2024 | 1.640 |
| April 11, 2024 | 1.671 |
| April 10, 2024 | 1.670 |
| April 09, 2024 | 1.699 |
| April 08, 2024 | 1.686 |
| April 05, 2024 | 1.691 |
| April 04, 2024 | 1.691 |
| April 03, 2024 | 1.727 |
| April 02, 2024 | 1.748 |
| April 01, 2024 | 1.758 |
| March 28, 2024 | 1.760 |
| March 27, 2024 | 1.762 |
| March 26, 2024 | 1.750 |
| March 25, 2024 | 1.740 |
| March 22, 2024 | 1.736 |
| March 21, 2024 | 1.755 |
| March 20, 2024 | 1.757 |
| Date | Value |
|---|---|
| March 19, 2024 | 1.753 |
| March 18, 2024 | 1.758 |
| March 15, 2024 | 1.772 |
| March 14, 2024 | 1.784 |
| March 13, 2024 | 1.790 |
| March 12, 2024 | 1.777 |
| March 11, 2024 | 1.800 |
| March 08, 2024 | 1.727 |
| March 07, 2024 | 1.700 |
| March 06, 2024 | 1.725 |
| March 05, 2024 | 1.654 |
| March 04, 2024 | 1.642 |
| March 01, 2024 | 1.687 |
| February 29, 2024 | 1.685 |
| February 28, 2024 | 1.715 |
| February 27, 2024 | 1.706 |
| February 26, 2024 | 1.724 |
| February 23, 2024 | 1.761 |
| February 22, 2024 | 1.748 |
| February 21, 2024 | 1.755 |
| February 20, 2024 | 1.750 |
| February 16, 2024 | 1.752 |
| February 15, 2024 | 1.745 |
| February 14, 2024 | 1.720 |
| February 13, 2024 | 1.711 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.522
Minimum
Dec 14 2023
4.542
Maximum
Dec 16 2021
2.933
Average
3.072
Median
Feb 04 2021
Price to Book Value Benchmarks
| Amgen Inc | 23.18 |
| Gilead Sciences Inc | 3.562 |
| Johnson & Johnson | 5.145 |
| Viking Therapeutics Inc | 8.135 |
| Moderna Inc | 2.935 |
Price to Book Value Related Metrics
| PE Ratio | 70.19 |
| PS Ratio | 2.455 |
| Price to Free Cash Flow | 29.96 |
| Price | 25.26 |
| Earnings Yield | 1.42% |
| Market Cap | 142.64B |
| Operating PE Ratio | 42.75 |
| Normalized PE Ratio | 23.74 |